Latest Pharmaceutical Industry News

Join Us as Pharmaceutical Freelancers

Hi there, Content Hub is now available! Keep Yourself in Tune with the Latest industry Dynamics

Brief Description of the Application of Hot Melt Extrusion in Pharmaceutical Formulations

Weekly Pharma News Review | PharmaSources.com (0130-0203) Industry Data PharmaSources.com February 06, 2023
NMPA announced the emergency drug review and approval, and conditionally approved the first-in-class innovative drugs, Simnotrelvir Tablets/Ritonavir Tablets of Hainan Simcere Pharmaceutical and Renmindevir of Shanghai Wangshi Biological Technology.
Weekly Pharma News Review | PharmaSources.com (1114-1118) Industry Data PharmaSources.com November 21, 2022
The news review of this week is from November 14 to 18, covering a total of 23 pieces of information in 3 sections, i.e., drug review, R&D, and business.
Weekly Pharma News Review | PharmaSources.com (1107-1111) Industry Data PharmaSources.com November 14, 2022
The news review of this week is from November 7 to 11, covering a total of 26 pieces of information in 3 sections, i.e., drug review, R&D, and business.
Weekly Pharma News Review | PharmaSources.com (1031-1104) Industry Data PharmaSources.com November 08, 2022
The news review of this week is from October 31 to November 4, covering a total of 25 pieces of information in 3 sections, i.e., drug review, R&D, and business.
Weekly Pharma News Review | PharmaSources.com (1024-1028) Industry Data PharmaSources.com October 31, 2022
The news review of this week is from October 24 to 28, covering a total of 23 pieces of information in 4 sections, i.e., drug review, R&D, business and listing.
Weekly Pharma News Review | PharmaSources.com (1017-1021) Industry Data PharmaSources.com October 24, 2022
The news review of this week is from October 17 to 21, covering a total of 21 pieces of information in 3 sections, i.e., drug review, R&D, and listing.
Weekly Pharma News Review | PharmaSources.com (1008-1014) Industry Data PharmaSources.com October 18, 2022
The most exciting thing for the industry is the first-in-class drug, Dorzagliatin Tablets, which is independently researched and developed by Hua Medicine was approved for marketing, becoming the first approved new drug for GKA diabetes in the world.
Weekly Pharma News Review | PharmaSources.com (0926-0930) Industry Data PharmaSources.com October 08, 2022
The news reviewed this week is from September 26 to 30, covering a total of 26 pieces of information in 4 sections, i.e. drug review, R&D, business and policy.
Weekly Pharma News Review | PharmaSources.com (0919-0923) Industry Data PharmaSources.com September 26, 2022
The news reviewed this week is from September 19 to 23, covering a total of 25 pieces of information in 4 sections, i.e. drug review, R&D, and business and listing.
Weekly Pharma News Review | PharmaSources.com (0912-0916) Industry Data PharmaSources.com September 20, 2022
The news reviewed this week is from September 12 to 16, covering a total of 26 pieces of information in 3 sections, i.e., drug review, R&D, and business.

Advertising Email to: Julia.zhang@imsinoexpo.com

Media Cooperation Email to: Jennifer.Yang@imsinoexpo.com
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Subscribe Join Us

Note: You can unsubscribe from the alerts at any time.